David Cory
Chief Executive Officer at LIB Therapeutics LLC
Net worth: 29 885 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Evan Stein | M | 77 |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | 9 years |
Thomas Dietz | M | 60 |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | 9 years |
David Apelian | M | 59 | 7 years | |
Lisa Kelly-Croswell | F | 57 | 2 years | |
Marianne T. Armstrong | M | 69 | 22 years | |
Amit Sachdev | M | 56 | 5 years | |
August Troendle | M | 67 |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | 9 years |
Evan Loh | M | 65 | 7 years | |
Kim Sablich | F | 55 | 3 years | |
Elizabeth Stoner | M | 73 |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | 8 years |
Richard A. Franco | M | - | 8 years | |
Christopher Kurtz | M | 57 | 2 years | |
Jesse Geiger | M | 49 |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | 9 years |
Stephen Ewald | M | 54 |
LIB Therapeutics LLC
LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | 9 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Glenn | M | 61 |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | 16 years |
Jim Shaffer | M | 57 |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA.
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | 14 years |
Erik Atkisson | M | 52 | 2 years | |
Sriram Ryali | M | 43 | 5 years | |
Stephana Patton | M | - | 2 years | |
Eldon Mayer | M | 62 | 6 years | |
Ann Hanham | M | 71 | 2 years | |
Edgar Engleman | M | 78 | 1 years | |
Sharon Barbari | F | 70 | 2 years | |
Nina Kjellson | F | 49 | 1 years | |
Christine Murray | F | 63 | 5 years | |
Stephen N. Rosenfield | M | 74 | 4 years | |
James Welch | M | 66 | 2 years | |
Robert S. Whitehead | M | 74 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | 1 years |
Jonathan Leff | M | 55 | 12 years | |
Art Mandell | M | 71 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | - |
Charles Bramlage | M | 63 | 2 years | |
Timothy Patrick Lynch | M | 54 | 3 years | |
Matt Bryant | M | - | - | |
Steven Bryant Porter | M | 66 | 11 years | |
Mark Mannebach | M | - | - | |
William H. Washecka | M | 76 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | 2 years |
Sarah Mathieson | F | - | 1 years | |
Joanne Quan | M | 60 | - | |
Susan Vermeir | F | - | 5 years | |
Shelly Xiong | M | - | - | |
Christopher Flint O'Brien | M | 67 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | 2 years |
Malcolm McKay | M | - | 4 years | |
Michael E. Markels | M | - | 1 years | |
Marianne A. Porter | M | 69 | 10 years | |
Russell T. Kawahata | M | - | 4 years | |
Williamson Z. Bradford | M | 62 | - | |
Keith Vendola | M | 52 |
DiObex, Inc.
DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | - |
Elizabeth A. Olek | M | 59 | 1 years | |
Gregory Flesher | M | 54 | 4 years | |
Michael S. Eison | M | - | - | |
David Stamler | M | 63 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | 3 years |
Scott D. Seiwert | M | 57 | - | |
Brian Stuart Murphy | M | 66 |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | 5 years |
Richard B. Love | M | 62 | 3 years | |
Melvin Booth | M | 79 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | - |
Curtis L. Ruegg | M | 61 | 2 years | |
Debra A. Odink | M | 60 | - | |
Bernice Welles | M | 71 |
DiObex, Inc.
DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | 3 years |
William Halter | M | 63 | 4 years | |
Lawrence Blatt | M | 62 | 6 years | |
James Pennington | M | 81 | 3 years | |
W. Scott Harkonen | M | - | 4 years | |
David Happel | M | 62 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 63 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Cory
- Personal Network